About
Telo Genomics Corp (V:TELO) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 14 2026
Telo Genomics Announces Study with University of Athens to Advance Next-Generation MRD Risk Stratification in Multiple Myeloma
Mar 31 2026
Telo Genomics Announces Appointment of John Farlinger as CEO and Chairman
Mar 9 2026
Telo Genomics Closes Second and Final Tranche of Convertible Debentures Financing
Feb 27 2026
Telo Genomics Corp. Announces Upsizing of Previously Announced Private Placement
Feb 18 2026
Telo Genomics Closes First Tranche of Convertible Debentures Financing
Financials
Revenue
CA$0
Market Cap
CA$5.52 M
EPS
-0.02
Translate